Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

S-ketamine for Cortical Spreading Depolarisation in Patients With Severe Acute Brain Injury

NCT05095857 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT05095857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05095857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
S-ketamine for Cortical Spreading Depolarisation in Patients With Severe Acute Brain Injury
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 4
Overall status
Recruiting
Start date
September 15, 2023
Completion date
September 15, 2028
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage, subarachnoid hemorrhage, aneurysmal, traumatic brain injury